Follow the Marksans Pharma Limited share price and the full insider trade history of the company, a listed equity based in India. Shares are quoted on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Marksans Pharma Limited has recorded 13 insider filings. Market capitalisation: €111.6bn. The latest transaction was reported on 6 June 2024 (Purchase). Among the most active insiders: Arvind Singh. Every trade is free.
13
Insider Decl.
0
Thresholds
€1m
7 ops.
Buy Volume
€31,575
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Marksans Pharma Limited Strong Buy (bullish), based on 3 analysts. Average price target: ₹266.00.
10Σ signal
Buys €1m€31,575 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,884 of 26,211 companies
61.4
score / 100
Value
45
Quality
78
FCF yld2.7%
Earn yld3.4%
EV/EBITDA18.6x
ROE15%
Gross mgn57%
Net mgn14%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.